Zoetis Inc. announced on December 9, 2024, the global launch of its new screenless point-of-care hematology analyzer, Vetscan OptiCell™, at the Veterinary Meeting & Expo (VMX) in January. This device is the first cartridge-based, artificial intelligence (AI) powered diagnostic tool for veterinary hematology.
Vetscan OptiCell™ provides complete blood count (CBC) analysis with accurate insights in minutes, utilizing proprietary microfluidic technology called viscoelastic focusing (VEF). This technology aligns cells in a single layer for sharp focus imaging, minimizing errors and enabling platelet recognition within clumps.
The system's single-use cartridge contains the blood sample, all reagents, and waste, offering ease of use, minimal maintenance, and no calibration requirements. This innovation aims to simplify and strengthen in-clinic diagnostics, helping veterinarians save money and reallocate time to patient care.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.